Kayne Anderson Rudnick Investment Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-50	Closed	-$5K	–	655
2022 Q1	$5K	Buy	50 +49	+4,900%	+$4.9K	﹤0.01%	567
2021 Q4	$0	Buy	+1	New	–	﹤0.01%	652
2021 Q1	–	Sell	-13	Closed	-$1K	–	670
2020 Q4	$1K	Buy	+13	New	+$1K	﹤0.01%	635